Join
Live feed
·
INSIDERFilingvia Quantisnow
Apimeds Pharmaceuticals US Inc. logo

Large owner Inscobee Inc. bought $2,000,000 worth of shares (500,000 units at $4.00) and converted options into 297,133 shares, increasing direct ownership by 37% to 2,028,657 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track APUS (Apimeds Pharmaceuticals US Inc.) and more on Quantisnow.